[go: up one dir, main page]

AU3086897A - Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc - Google Patents

Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Info

Publication number
AU3086897A
AU3086897A AU30868/97A AU3086897A AU3086897A AU 3086897 A AU3086897 A AU 3086897A AU 30868/97 A AU30868/97 A AU 30868/97A AU 3086897 A AU3086897 A AU 3086897A AU 3086897 A AU3086897 A AU 3086897A
Authority
AU
Australia
Prior art keywords
manganese
zinc
magnesium
calcium
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU30868/97A
Inventor
Hans Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPR-INSTITUTE FOR PHARMACEUTICAL RESEARCH AG
Original Assignee
IPR INST PHARM RES RIEHEN AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPR INST PHARM RES RIEHEN AG filed Critical IPR INST PHARM RES RIEHEN AG
Publication of AU3086897A publication Critical patent/AU3086897A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU30868/97A 1996-06-28 1997-06-25 Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc Withdrawn AU3086897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96110445 1996-06-28
EP96110445 1996-06-28
PCT/CH1997/000252 WO1998000148A1 (en) 1996-06-28 1997-06-25 Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Publications (1)

Publication Number Publication Date
AU3086897A true AU3086897A (en) 1998-01-21

Family

ID=8222944

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30868/97A Withdrawn AU3086897A (en) 1996-06-28 1997-06-25 Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Country Status (3)

Country Link
AR (1) AR007638A1 (en)
AU (1) AU3086897A (en)
WO (1) WO1998000148A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298420B1 (en) * 1996-11-19 2000-01-05 Monsanto It Spa USE OF CREATINE IN CARDIO-RESPIRATORY INSUFFICIENCY
JP3384539B2 (en) * 1997-09-05 2003-03-10 義之 内田 Asthma treatment
EP1002532A1 (en) * 1998-11-19 2000-05-24 K.U. Leuven Research & Development Prevention of aging effects and treatment of muscle atrophy
US8613959B2 (en) 2009-02-10 2013-12-24 Fhg Corporation Dietary supplements containing extracts of Nelumbo and processes of using same
JP2018537987A (en) * 2015-12-18 2018-12-27 ロンザ インコーポレイテッド Methods and compositions for increasing muscle protein synthesis and / or functional strength in mammals and methods for producing the compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221827A1 (en) * 1982-06-09 1983-12-15 DSO Pharmachim, Sofija BIOSTIMULATING AGENT
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot

Also Published As

Publication number Publication date
AR007638A1 (en) 1999-11-10
WO1998000148A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
AU3455297A (en) Pharmaceutical composition containing acid addition salt of basic drug
AU3988297A (en) Stabilized fluids containing soluble zinc
AU8122994A (en) Slipper
AU2930597A (en) Salt compositions
AU5938196A (en) Stabilization of polynucleotide complexes
AU4778500A (en) Composition containing ascorbic acid salt
AU1282795A (en) Prostaglandin derivative, salt thereof, and use thereof
EP0848736A4 (en) Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
AU1135499A (en) Medicine for promoting cicatrization and containing thrombocytes
AU4330097A (en) Pharmaceutical compounds
AU3086897A (en) Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc
AU6707096A (en) Alpha-methoxymethylene or alpha-methoxyimino naphthylacetic acid derivatives and their use as fungicides
AU6098296A (en) Low ph antimicrobial food composition
ZA975755B (en) Useful formulations of acid addition salt drugs.
AU4867499A (en) Shoelace warning system
AU4169897A (en) Pharmaceutical compounds
AU4633796A (en) Benzoxazepine derivatives, salts thereof, and drugs containing the same
AU6229898A (en) Derivatives of cyclodepsipeptide, pf1022 substance
AU1120595A (en) Novel indole or salt thereof
AU4308897A (en) Electrolytic treatment of aqueous salt solutions
AU5654399A (en) Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
AU4107797A (en) Compounds for the treatment and prevention of diabetes
AU1265997A (en) Substituted thiophenylalkenylcarboxylic acid guanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
AUPP355498A0 (en) Salt poultice
AU6386799A (en) Hydrophilic synthetic blood vessels